Withdrawal time (WT) has been proposed as a quality indicator for colonoscopy based on evidence that it is directly related to the rate of adenoma detection. Our objective was to test the hypothesis that baseline WT is inversely associated with the risk of fi nding neoplasia at interval colonoscopy.
INTRODUCTION
Colonoscopy has become an integral modality for colorectal cancer screening and is increasing in frequency (1, 2) . Early detection and removal of adenomatous polyps by colonoscopy decreases the risk of progression to cancer (3 -5) . However, rates of adenoma detection can vary among individual endoscopists (6, 7) . Th e eff ect of this variation is amplifi ed when one considers that greater than 14 million colonoscopies are performed yearly in the United States (8) .
Factors leading to variation in polyp detection are only beginning to be understood. A Canadian study found that risk factors for interval colorectal cancer within 3 years of a colonoscopy included performance of the colonoscopy in an offi ce setting or performance by an internist or family physician (9) . Second, colonoscopy withdrawal time (WT) has been shown to be related to adenoma detection rate in several studies (6, 7) and the US Multi-Society Task Force recommended in 2002 that optimal WT for normal colonoscopies should average 6 -10 min (10) .
It follows, then, that if a longer WT is associated with an increased rate of adenoma detection then it should also be associated with a decreased risk of future advanced adenomas and cancer. However, this relationship has not yet been evaluated. Our hypothesis is that, aft er adjusting for other factors that may infl uence the development of neoplasia, WT at baseline colonoscopy will be inversely associated with the risk of developing advanced neoplasia at 5 years.
METHODS

Setting and study participants
As part of VA Cooperative Study 380, participants were enrolled in 13 Veterans Aff airs Medical Centers geographically distributed across the United States between February 1994 and January 1997 as described earlier (11) . Veterans aged 50 -75 years were invited to participate. Exclusion criteria included symptoms of disease of the lower gastrointestinal tract, prior disease of the colon, structural examination of the colon within the previous 10 years, or any contraindication to colonoscopy. At enrollment, interviews were conducted to measure potential risk factors for colon neoplasia, including family history of colon cancer in a fi rst degree relative, past, and current tobacco and alcohol use, physical activity index (12) , body mass index, presence of diabetes, and use of non-steroidal anti-infl ammatory drugs.
A total of 17,732 patients were screened for enrollment; 2,346 patients declined to complete the survey. Among the patients who met eligibility criteria, 1,463 (31.4 % ) declined to participate, 3,196 eligible patients were enrolled, and 3,121 had complete colonoscopy examination to the cecum. If patients had repeat examinations within 6 months of the baseline examination, the additional fi ndings were included as part of the baseline fi ndings; this additional examination occurred in 6.0 % of patients.
Th e study protocol was approved by a central Human Rights Committee and by Institutional Review Boards at each participating center. Th is paper describes additional analysis of the study cohort. No new data collection was undertaken.
Study protocol
Eligible subjects, aft er providing written informed consent, received a polyethylene glycol-based electrolyte solution for bowel preparation and colonoscopy was performed as described earlier (11) . Th e center principal investigator or faculty designate was personally involved in the colonoscopy procedure. Th e study protocol did not allow trainees to perform these exams without direct supervision. Bowel preparation was assessed as good (mucosa well seen throughout), fair (liquid contents; exam adequate), or poor (solid contents; exam compromised). Total procedure time and insertion time were recorded prospectively by study nurses. Insertion time was defi ned as the time from scope insertion to the time the cecum was reached. Cecal intubation was confi rmed in all cases by photographing cecal landmarks. WT was calculated by subtracting insertion time from total procedure time. If polyps were identifi ed, they were photographed with an open biopsy forceps touching the polyp to confi rm size. All polyps were removed when possible with the exception of multiple small rectal polyps in which up to six biopsies were taken to sample for adenomatous tissue. Pathology was interpreted by the local pathologist and sent for blinded central pathology review. When there was disagreement, a third blinded pathologist also reviewed the tissue.
In addition to polypectomies, select patients also underwent 4 -8 random rectal biopsies to sample normal appearing mucosa for an ancillary study. In the group of patients without polyps at baseline, only the 300 patients who returned for follow-up underwent biopsies. Th ese biopsies were generally completed in about 1 min at the conclusion of the colonoscopy. Th e exclusion of these biopsies from total procedure time was not explicitly prescribed in the study protocol. However, at the site of the CSP 380 principal investigator (D.L.), biopsies were not included as part of the procedure time.
Th e surveillance plan has been described earlier (13) . Patients with neoplasia at baseline were assigned to follow-up depending on the baseline pathology. Patients with cancer or adenomas with high-grade dysplasia were followed based on physician decisions. Patients with villous adenomas or adenomas ≥ 10 mm were assigned to have repeat colonoscopies at 2 and 5 years aft er the baseline exam. Patients with small tubular adenomas were randomly assigned to follow-up at 2 and 5 years or 5 years only for surveillance. A portion of patients with no polyps at baseline were matched by age to patients with adenomas ≥ 10 mm and assigned to surveillance at 5 years. Th ere was a 6-month scheduling window for return procedures provided for in study protocol.
Outcomes and measurements
Advanced colonic neoplasia was defi ned as an adenoma of 10 mm of more, a villous or tubulovillous adenoma (at least 25 % villous), adenoma with high-grade dysplasia or intramucosal carcinoma, or invasive cancer. Invasive cancer was defi ned as invasion of malignant cells beyond the muscularis mucosa.
" Baseline colonoscopy " was defi ned as colonoscopy performed at study entry or within 6 months of study entry if a repeat examination was required to clear the colon. " Interval colonoscopy " refers to the follow-up colonoscopy performed within 5.5 years. Neoplastic lesions detected during this colonoscopy were defi ned as " interval neoplasia. " Neoplasia included small adenomas and advanced colonic neoplasia.
Data analysis
Th e relationship between WT and risk of neoplasia at followup was examined in two ways. First, a patient-level analysis was undertaken examining the risk of interval neoplasia in patients without polyps at baseline. Th e baseline colonoscopy WT was compared across patients with and without neoplasia at interval colonoscopy using t -tests for continuous measures. We then performed bivariate comparisons of WT and risk of interval adenoma across a number of purported risk factors for interval colon neoplasia, including age, gender, race (White compared to non-White), prep quality at baseline, body mass index (divided into quintiles), physical activity index (14) 29 -36; and 37 + ), family history of colorectal cancer in fi rst-degree relatives, tobacco or alcohol use at baseline, diabetes and daily non-steroidal anti-infl ammatory drug (NSAID) use at baseline. Th ese were factors that were also hypothesized to aff ect WT and hence potentially confound the relationship between WT and interval neoplasia detection. T -tests and ANOVA were used for continuous measures and χ 2 for categorical comparisons. Bonferonni adjustment was performed to account for multiple comparisons. Finally, we evaluated the various risk factors for neoplasia at 5.5 years using a stepwise logistic regression modeling approach. Th e model included WT and age with the remaining factors determined by the selection procedure. With WT and age in the model, the only signifi cant risk entered by the selection process was the physical activity index.
Th e second part of the analysis was performed at the center level. We calculated the mean WT for each center based on all 1,441 subjects without polyps at baseline colonoscopy. We then examined the correlation (Spearman correlation) between mean WT by center and baseline adenoma detection rate in all patients from each center. We also examined the correlation between mean WT by center and interval neoplasia detection rate in the cohort of patients from each center who returned for surveillance within 5.5 years. Th e interval neoplasia rates would thus include those patients with no polyps at baseline and those who had their polyps removed during baseline colonoscopy.
All data were analyzed at the Veterans Aff airs Cooperative Study coordinating center in Perry Point, MD. Management of the study data base and all statistical analyses were performed with SAS soft ware (SAS Institute, Cary, NC). All P values are two-sided.
RESULTS
One thousand one hundred and ninety-three subjects returned by protocol for colonoscopic surveillance within 5.5 years (mean = 3.4 years, s.d. = 1.5 years). During surveillance, bowel preparation was described as good in 81.8 % of patients, fair in 12.7 % , and poor in 5.5 % . Of 1,441 that were without polyps at baseline, 304 subjects returned for follow-up colonoscopy (mean = 4.8 years). Of the 304 subjects without polyps at baseline who were followed up, 49 subjects (16.2 % ) had interval neoplasia including 7 with advanced adenomas and 1 with invasive cancer. Two of the 304 follow-up patients did not have baseline WT recorded and were excluded from the analysis.
Th e characteristics of the study cohort are listed in Table 1 . Th ere were no statistically signifi cant diff erences in proposed risk factors for neoplasia in the group with interval neoplasia as compared with those without neoplasia. Th ere was a higher proportion of patients with family history of colon cancer that returned for surveillance. Th e prep quality at baseline was good in over 80 % of patients.
Th e unadjusted results of the patient-level analysis are detailed in Table 2 . Th e average WT at baseline colonoscopy in subjects with neoplasia on follow-up was 15. Baseline WT ranged from 1 to 57 min and 1 to 55 min in patients with and without neoplasia on follow-up. Seventy-fi ve percent of subjects that returned for surveillance had baseline WT greater than 8 min. Table 3 describes the baseline colonoscopy WT and rates of interval neoplasia in relation to the potential confounding variables. Aft er Bonferroni adjustment, none of the variables we examined were signifi cantly associated with average WT or an increased risk of interval neoplasia. In our logistic regression model, baseline colonoscopy WT was not independently associated with the risk of interval neoplasia (OR 1.03, P = 0.07) aft er adjusting for age, prep quality, body mass index, and physical activity index. Only increased physical activity index was an independent predictor of risk of interval neoplasia in patients with no polyps at baseline (OR 1.04, 95 % CI 1.01 -1.08).
Th e results of the center-level analysis are summarized in Table 4 and Figure 1 . Average WT ranged from 5.2 to 25.6 min and was correlated with the detection rate for adenomas (Spearman correlation coeffi cient ( r ) = 0.61, P = 0.03) but not advanced neoplasia ( r = 0.26, P = 0.40) at the baseline colonoscopy. However, if the center with the fastest average WT (5.2 min) was eliminated, the correlation with adenoma detection was no longer seen. Th ere was no correlation of WT with average polyp size ( r = − 0.42, P = 0.15) though the center with the fastest WT did have a larger average polyp size when compared with the other centers. WT at baseline was neither associated with fi nding interval neoplasia ( r = 0.16, P = 0.61) nor with interval advanced neoplasia ( r = 0.21, P = 0.49).
DISCUSSION
Th is study is the fi rst to examine the impact of WT at baseline with metachronous or missed adenomas. Contrary to our hypothesis, our analysis did not identify an association between WT at baseline colonoscopy and risk of neoplasia on follow-up colonoscopy within 5.5 years. Th e medical center-level analysis did detect a positive correlation between WT and adenoma detection rate, corroborating the results of previously published studies (6, 7) . However, our data suggest that a threshold may exist between 5.2 and 8.6 min beyond which WT may no longer be correlated with adenoma detection.
Our results could be explained by the concept that longer WT leads to the increased removal of clinically insignifi cant polyps. In fact, prior studies have suggested that the perceived association between WT and polyp detection is primarily driven by the detection of polyps < 5 mm (15) . Furthermore, in the study by Barclay et al ., (6) mean polyp size was negatively correlated with average WT in procedures in which no polyps were removed (Spearman rank correlation coeffi cient − 0.57, P = 0.05). Th e challenge in translating these results into practice rests in the fact that the preventive benefi t of colonoscopy is based on studies in which all detected polyps were removed, regardless of size (16) . It is unclear whether the same protective eff ect would be demonstrated with screening strategies in which diminutive polyps are left intact.
ENDOSCOPY
Withdrawal Time and Risk of Neoplasia
Another potential explanation for our fi ndings is the possibility that a longer WT at baseline is a marker for a more diffi cult exam rather than a more careful exam. Although our analysis was not designed to identify determinants of WT, we did fi nd that patients receiving narcotics in addition to midazolam had a longer average WT than those receiving midazolam alone (data not shown). If patients with a longer WT had a more diffi cult exam, then it may be possible that more lesions were missed in procedures with longer WTs. Th us, the potential protective eff ect of a longer WT (i.e., careful examination) might be diluted by the increased likelihood of missed lesions.
Our fi ndings must be interpreted in the context of the study limitations. Our power to detect meaningful diff erences in interval neoplasia risk at the patient level is limited by the small number of cases of interval neoplasia in our patient-level cohort. Indeed, our observed association between baseline WT and interval neoplasia, albeit marginal, bordered on statistical signifi cance. Th is limitation was partly because of the original study design, in which only a small percentage of patients without polyps at baseline were invited to return for surveillance. We undertook the center-level analysis, in part, to overcome the sample size limitation and minimize the risk of making a type 2 statistical error. Additionally, the 5-year follow-up interval may have been too short to see a large eff ect on risk of advanced neoplasia.
Another limitation of our study is the possibility of residual confounding related to imperfect measures of colonoscopy quality. Th e protective eff ect of a colonoscopy is dependent on the identifi cation and removal of pre-cancerous polyps at baseline and again at the interval exam. We identifi ed WT as a proxy for quality at baseline, but similar measures of quality were not available to adjust the analysis of interval neoplasia. In fact, in our center-level analysis, there is a signifi cant variability in the detection rates for interval adenomas and advanced adenomas. Th is variability may relate to the quality of the baseline exam; however, it may also refl ect the quality of the surveillance exam. 
ENDOSCOPY
Withdrawal Time and Risk of Neoplasia
As with other studies conducted in the VA, our study cohort was largely limited to men, so these results may not be generalized to colonoscopies in women. Second, the average WTs in our study are considerably longer than those previously published in non-VA settings. In fact, in our study, < 10 % of subjects had WTs < 6 min. As a result, our fi ndings may not be generalizeable to settings with a shorter WT, especially if the relationship between these two variables is not linear. Some of discrepancy may be explained by the rectal biopsies taken as part of study protocol, though these biopsies were generally completed in about 1 min at the conclusion of the colonoscopy and were not uniformly included in procedure time. Nevertheless, recent studies performed within the veterans health-care system have reported average WTs comparable to our results (17, 18) , so there may be important unrecognized systematic diff erences between VA and non-VA health-care systems that make quality comparisons challenging. Th ese diff erences may relate to patient populations, health-care resource limitations, or systematic diff erences in the performance of colonoscopy, and they deserve further study before the application of existing quality measures to VA populations.
Although WT in our study and that reported outside the VA may be diff erent, the rates of interval neoplasia observed in our study mirror those reported in other patient populations. For example, the proportion of patients in our study with negative colonoscopies at baseline who developed cancer within 5 years (0.33 % ) are low, consistent with fi ndings reported by Singh et al . (19) (0.38 % ) in Canada. Moreover, the proportion of interval advanced adenomas in our study (2.3 % ) was actually higher than those published recently by Imperiale et al . (20) (1.1 % ) . Similarly, the rate of interval advanced neoplasia was also higher (2.6 % ) than a recently published Chinese screening cohort (1.4 % ) (21) . Th ese diff erences may refl ect diff erences in the patient population or variation in the quality of the baseline colonoscopy. In conclusion, in our study with a mean baseline WT of > 12 min, we identifi ed a modest positive correlation between WT and adenoma detection rate at the medical-center level, consistent with prior studies. However, baseline WT was not correlated with the detection of advanced adenomas at baseline or any interval neoplasia at follow-up colonoscopy within 5.5 years. Th e interpretation of these fi ndings is limited by our lack of shorter WTs as reported in other studies and small sample size. However, our results suggest that there is a limited range in which WT is a useful quality indicator for colonoscopy; this range may exist because of the increased removal of clinically insignifi cant polyps with increasing WTs above a certain threshold. Developing a better understanding of the signifi cance of diminutive colorectal polyps will be integral to the refi nement of existing quality measures including WT.
